DIAH

DIAH 2026

19 – 21 May 2026 | Bruges, Belgium

Canton Biologics Co., Ltd.

www.cantonbio.com/Guangzhou, China
16 profile visits

About

Welcome to the Canton Biologics booth — we're at B9!

Canton Biologics is a globally integrated CDMO, operating four core sites across China and Germany and serving over 100 biopharma clients worldwide.

Our capabilities span six advanced solution areas: Innovative Drug Solutions, Biosimilar Solutions, ATMP Solutions (including oncolytic viruses, CAR-T cell therapies, LBPs, and exosome-based therapies), Biologics Solutions for Companion Animals, Biologics Solutions for Livestock and Poultry, and Recombinant Products for Healthcare & Lifestyle. Supported by robust quality systems aligned with EMA, FDA, and NMPA standards, we enable the development of even the most challenging-to-express proteins.

We drive bioprocess innovation through high-titer expression platforms (up to 39 g/L), next-generation cell lines, proprietary vector systems, and accelerated DNA-to-BLA timelines.

Social media

Areas of Activity

Services

Representatives

Xiao Shen

CEO

Canton Biologics Co., Ltd.

Guangcai Ren

Vet-Bio Vice President

Canton Biologics Co., Ltd.